Sweden· SE-20160420000012
Veltassa 8,4 g Pulver till oral suspension
A medicinal product containing patiromer, registered in Sweden by Vifor Fresenius Medical Care Renal Pharma France.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Patiromer
- Manufacturer
- Vifor Fresenius Medical Care Renal Pharma France
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20160420000012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Patiromer in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaVELTASSAVIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
- SpainVELTASSA 8,4 G POLVO PARA SUSPENSION ORALVifor Fresenius Medical Care Renal Pharma France
- NorwayVeltassaVifor Fresenius Medical Care Renal Pharma France
- PolandVeltassaVifor Fresenius Medical Care Renal Pharma France
- United StatesVELTASSAVifor Pharma, Inc.
- SwitzerlandVeltassa 16.8 g, Pulver für orale SuspensionVifor Fresenius Medical Care Renal Pharma Ltd.
- ItalyVELTASSA*orale polv 30 bust 16,8 gVIFOR FRESENIUS M.C.R.P.FRANCE
- Japanパチロマーソルビテクスカルシウムゼリア新薬工業
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Veltassa
- Liechtenstein · Veltassa
- Norway · Veltassa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1f2a4557-710e-45c0-aae1-90ec9df92b1b GET /v1/drugs/1f2a4557-710e-45c0-aae1-90ec9df92b1b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20160420000012",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20160420000012",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/veltassa"
}See everything about patiromer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.